Lannett Co Inc (LCI) Position Raised by State of Alaska Department of Revenue
State of Alaska Department of Revenue boosted its stake in shares of Lannett Co Inc (NYSE:LCI) by 77.6% during the second quarter, Holdings Channel reports. The fund owned 5,753 shares of the company’s stock after buying an additional 2,513 shares during the period. State of Alaska Department of Revenue’s holdings in Lannett Co were worth $117,000 as of its most recent SEC filing.
Several other hedge funds have also recently made changes to their positions in LCI. Mason Street Advisors LLC increased its stake in shares of Lannett Co by 7.5% in the first quarter. Mason Street Advisors LLC now owns 6,870 shares of the company’s stock valued at $154,000 after buying an additional 482 shares during the last quarter. Airain ltd purchased a new stake in shares of Lannett Co during the first quarter valued at approximately $205,000. Neuberger Berman Group LLC purchased a new stake in shares of Lannett Co during the first quarter valued at approximately $209,000. Cutter & CO Brokerage Inc. bought a new position in Lannett Co during the first quarter valued at $255,000. Finally, Globeflex Capital L P boosted its position in Lannett Co by 87.5% in the first quarter. Globeflex Capital L P now owns 11,920 shares of the company’s stock valued at $266,000 after buying an additional 5,561 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.
Lannett Co Inc (NYSE LCI) traded up 1.55% during trading on Friday, reaching $16.40. 769,048 shares of the company traded hands. The company’s market capitalization is $610.57 million. Lannett Co Inc has a 52 week low of $15.75 and a 52 week high of $39.99. The firm has a 50-day moving average price of $20.02 and a 200-day moving average price of $21.30.
Several research firms recently weighed in on LCI. BidaskClub cut shares of Lannett Co from a “sell” rating to a “strong sell” rating in a research note on Tuesday. Zacks Investment Research raised shares of Lannett Co from a “hold” rating to a “buy” rating and set a $25.00 target price for the company in a research note on Tuesday, July 18th. Deutsche Bank AG reaffirmed a “hold” rating and set a $23.00 target price (up from $22.00) on shares of Lannett Co in a research note on Monday, July 17th. Oppenheimer Holdings, Inc. reaffirmed a “hold” rating on shares of Lannett Co in a research note on Thursday, June 8th. Finally, ValuEngine cut shares of Lannett Co from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have assigned a buy rating to the company’s stock. Lannett Co presently has an average rating of “Hold” and a consensus price target of $27.50.
About Lannett Co
Lannett Company, Inc develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc As of June 30, 2016, the Company’s products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules.
Want to see what other hedge funds are holding LCI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lannett Co Inc (NYSE:LCI).
Receive News & Ratings for Lannett Co Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lannett Co Inc and related companies with MarketBeat.com's FREE daily email newsletter.